Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC

Recruiting now · Phase 3

Conditions studied: Nasopharyngeal Cancinoma (NPC)

In brief

The goal of this phase 3 non-inferiority trial is to compare the efficacy and toxicity of proton or photon radiation therapy plus carbon ion radiation therapy for newly diagnosed nasopharyngeal carcinoma. The main question it aims to answer is that if proton radiation therapy plus carbon ion radiation therapy is non-inferior to photon radiation therapy plus carbon ion radiation therapy in terms of therapeutic efficacy. Participants will be randomized to receive either proton radiation therapy (arm 1) or photon radiation therapy (arm 2), in addition to carbon ion radiation therapy (for both arms).

Key facts

Study ID
NCT06846450
Run by
Lin Kong, MD
People needed
470
Starts
2025-04-01
Expected to finish
2031-01-31
Last updated by the study team
2025-12-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.